logo

Sophiris Bio Inc. (SPHS)



Trade SPHS now with
  Date
  Headline
8/9/2019 8:08:38 AM  Sophiris Bio Q2 Net Loss $2.2 Mln Or $0.07/shr Vs Loss $6.1 Mln Or $0.20/shr Prior Year
6/19/2019 8:56:00 AM Sophiris Bio Gets Positive Feedback From EMA Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design
5/9/2019 4:27:02 PM Sophiris Bio Q1 Loss/share $0.08 Vs. Loss $0.11 Year Ago
12/17/2018 8:11:47 AM Sophiris Bio Updates On Phase 2b Localized Prostate Cancer Trial
6/25/2018 8:39:30 AM Sophiris Bio Reports Interim Safety And Biopsy Findings For Phase 2b Trial Of Topsalysin In Localized Prostate Cancer